Advertisement

Topics

Latest Bariatric Surgery NewsRSS

09:25 EDT 25th September 2017 | BioPortfolio

Stratpharma Takes Top Honors Across Multiple Categories in the 2017 Aesthetic Everything Diamond Crystal Awards

Stratpharma Inc. USA, a U.S. subsidiary of Stratpharma AG, the Swiss company that specializes in innovative film-forming full-contact topical medical products to improve medical and aesthetic outcomes in post-procedure care in aesthetic dermatology, plastic surgery, and radiation oncology, has been selected as winner in four categories of the p

Global and Regional Surgical Mesh Market Research Report 2017 [Report Updated: 20092017] Prices from USD $3500

SummarySurgical mesh is a loosely woven sheet which is used as either a permanent or temporary support for organs and other tissues during surgery. Surgical mesh is created from both inorganic and biological materials and is used in a variety of surgeries. Though hernia repair surgery is the most common application, it can also be used for reconstructive work, such as in pelvic organ prolapse.Mark...

Global and Regional Surgical Robots Market Research Report 2017 [Report Updated: 20092017] Prices from USD $3500

SummarySurgical robot can be controlled through computer program to assist surgery. A surgical robot t allows surgeons greater access to areas under operation using more precise and less invasive methods.Market Segment as follows:By Region AsiaPacific North America Europe South America Middle East AfricaBy Type Laparoscopy Orthopedics OthersBy Application Open Surgery ...

Global and Regional Surgical Stapling Devices Market Research Report 2017 [Report Updated: 20092017] Prices from USD $3500

SummarySurgical Stapling Device is medical device which is used to place surgical staples. Surgical staples are specialized staples used in surgery in place of sutures to close skin wounds, connect or remove parts of the bowels or lungs.Market Segment as follows:By Region AsiaPacific North America Europe South America Middle East AfricaBy Type Straight Surgical Stapling Devices ...

Global and Regional Antimicrobial Suture Market Research Report 2017 [Report Updated: 14092017] Prices from USD $3500

SummaryThis report studies the Antimicrobial Suture market, Suture is a specific linear suture material which is used in surgery or trauma dispose for hemostasis and tissue suturing. They also are used to close incisions from surgery. A suture is a medical device used in wound closure.Market Segment as follows:By Region AsiaPacific North America Europe South America Middle East Afr...

Global Enteric Empty Capsules Market Data Survey Report 2025 [Report Updated: 07092017] Prices from USD $1500

SummaryEnteric Empty Capsules is a niche type of empty capsules that can prevent the material inside destroyed in gastric area.The global Enteric Empty Capsules market will reach Volume Million USD in 2017 with CAGR xx% 20182025. The main contents of the report including:Global market size and forecastRegional market size, production data and export importKey manufacturers manufacturing sites, ca...

Synthetic Aperture Radar Market by Frequency Band X, L, C, S, K/Ku/Ka, UHF/VHF, Component Receiver, Transmitter, Antenna, Platform Airborne, Ground, Application Area Defense, Commercial, Mode Multimode, Single mode, and Region Global Forecast to 2022 [Re

The synthetic aperture radar market is projected to grow at a CAGR of 11.75% from 2017 to 2022.The synthetic aperture radar market is projected to grow from USD 2.41 billion in 2017 to USD 4.21 billion by 2022, at a CAGR of 11.75% from 2017 to 2022. The growing demand for technologies providing situational awareness, increasing deployment of spacebased radars, and geopolitical instabilities in the...

Northern Virginia Anesthesia Groups Grant Anesthesia EMR Vendor Agreement to Plexus TG

JACKSON, Mich., Sept. 25, 2017 /PRNewswire/ -- Plexus Technology Group, LLC (Plexus TG), a market-leading, best-of-breed anesthesia information management systems (AIMS) provider, announces they were chosen by Reston Anesthesia Associates, P.C., Stonesprings Anesthesia Associates, LTD and Outpatient Anesthesia Services of Reston to install their anesthesia documentation solution in two acute care ...

Viking Therapeutics to Host Key Opinion Leader Event to Discuss Musculoskeletal Therapeutics in Hip Fracture and Other Settings

SAN DIEGO, Sept. 25, 2017 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that it will host a key opinion leader (KOL) presentation and webcast to highlight the current unmet need in post-fracture therapy and discuss the company's lead...

Gelesis100 Achieves Significant Weight Loss with Excellent Safety Profile in Pivotal Study

58% of treated adults lost 5% or more of their weight over six months, and almost twice as many individuals achieved 10% or more weight loss compared to placebo Study exceeded one of two co-primary endpoints and Company plans to move forward with submission for regulatory approvals Gelesis, a biotechnology company developing first-in-c...

Agilent Receives Expanded FDA Approval For The Use Of Dako PD-L1 IHC 22C3 Pharmdx Companion Diagnostic In Gastric Or Gastroesophageal Junction (GEJ) Cancer

Patients with gastric or GEJ adenocarcinoma whose tumors express PD-L1 can now be identified for potential treatment with KEYTRUDA (pembrolizumab) using PD-L1 IHC 22C3 pharmDx SANTA CLARA, Calif.--(BUSINESS WIRE)--Third paragraph of release...

IK+EM Study Released at EASD Shows Similar Outcomes Between Gastric Plication and EndoBarrier

GI Dynamics®, Inc. (ASX:GID), a medical device company that has commercialized EndoBarrier® in Europe, the Middle East and South America for patients with type 2 diabetes and obesity, announces that new data has been released from the Institute for Clinical and Experimental Medications (“IK+EM”) on the comparison of 40 patients who underwent either g...

Mohawk Tribe Attempts To Dismiss Allergan Patent Case

I believe AGN's growth is dead and it might lack the R&D prowess to replace a loss of Restasis . The fight to protect Allergan's Restasis patents is heating up.

Global States Ambulatory Surgery Center Market Data Survey Report 2025 [Report Updated: 30082017] Prices from USD $1500

SummaryAmbulatory Surgery Centersknown as ASCsare modern health care facilities focused on providing sameday surgical care, including diagnostic and preventive procedures.An ambulatory surgery center is a specialized outpatient facility where patients undergo surgical procedures without having to be admitted to a hospital. Patients leave the same day they are treated usually within a few hours. I...

Israeli Startup Augmedics Lands $8.3M for Augmented Reality Glasses for Spinal Surgery

Augmedics, a Yokneam, Israel-based developer of an augmented-reality (AR) surgical visualization system has raised $8.3M in Series A funding led by AO Invest, Israeli Innovation Authority, Terra Venture Partners and other undisclosed investors. The company plans to utilize the latest round of funding accelerate research and development as well as pre-clinical and clinical trials of ... Read More

CORRECTING and REPLACING Agilent Technologies Receives Expanded FDA Approval for the Use of Dako PD-L1 IHC 22C3 pharmDx Companion Diagnostic in Gastric or Gastroesophageal Junction (GEJ) Cancer

Patients with gastric or GEJ adenocarcinoma whose tumors express PD-L1 can now be identified for potential treatment with KEYTRUDA® (pembrolizumab) using PD-L1 IHC 22C3 pharmDx Third paragraph of release should read: The expanded approvals for PD-L1 IHC 22C3 pharmDx and KEYTRUDA means that these patients now have the possibility of receiving a targete...

Agilent Technologies Receives Expanded FDA Approval for the Use of Dako PD-L1 IHC 22C3 pharmDx Companion Diagnostic in Gastric or Gastroesophageal Junction (GEJ) Cancer

Patients with gastric or GEJ adenocarcinoma whose tumors express PD-L1 can now be identified for potential treatment with KEYTRUDA® (pembrolizumab) using PD-L1 IHC 22C3 pharmDx Agilent Technologies Inc. (NYSE: A) today announced its Dako PD-L1 IHC 22C3 pharmDx assay has an expanded label approved by U.S. Food and Drug Administration (FDA), for use as ...

Transradial catheterization could permanently damage blood vessels

Transradial cardiac catheterization—an in vivo procedure that can diagnose and treat

Gurman says, ‘Our voice is their voice’ in explaining the importance of physician advocacy

At a time when the state of health care is in flux, it is critical that physicians engage in the national debate by telling their stories and those of their patients to help create change, according to Andrew W. Gurman, MD, immediate past president of the AMA.“Our country deserves better, and it is up to us as America’s doctors to keep the health and vitality of our patients, our fellow citize...

Misbah Khan MD, FAAD, FACMS is recognized by Continental Who's Who

MANHATTAN, N.Y., Sept. 22, 2017 /PRNewswire/ -- Misbah Khan MD, FAAD, FACMS is recognized by Continental Who's Who as a Pinnacle Lifetime Member specializing in the field of Dermatologic Surgery.           Dr. Khan's professional title is President and Founder of M Khan Dermatology and Cosmetic Surgery, specializing in Revision Liposuctio...

Japan Ministry of Health, Labor and Welfare Approves Opdivo (nivolumab) for the Treatment of Patients with Unresectable Advanced or Recurrent Gastric Cancer Which Has Progressed After Chemotherapy

Opdivo is the first and only Immuno-Oncology treatment to demonstrate survival benefit in patients who underwent two or more prior treatments Opdivo is the first Immuno-Oncology agent anywhere in the world to receive approval for unresectable advanced or recurrent gastric cancer based on a Phase 3 study Bristol-Myers

Anytime Fitness Releases Annual "Weight of the Union" Report

HASTINGS, Minn., Jan. 27, 2012 /PRNewswire/ -- In 2011, more Anytime Fitness members worked out late at night, cashed in on health insurance reimbursements and made March the busiest workout month. The statistics are part of the second annual Anytime Fitness "Weight of the Union" report, which examined the fitness and nutritional habits of its 1.3 million members. Anytime Fitness is the...

Dentists In China Successfully Used A Robot To Perform Implant Surgery Without Human Intervention, Reveals

  Life Sciences Jobs   ...

Japan Ministry Of Health, Labor And Welfare Approves Opdivo (Nivolumab) For The Treatment Of Patients With Unresectable Advanced Or Recurrent Gastric Cancer Which Has Progressed After Chemotherapy

  Life Sciences Jobs   ...

Bristol-Myers Squibb Release: Approves Opdivo (Nivolumab) For The Treatment Of Patients With Unresectable Advanced Or Recurrent Gastric Cancer Which Has Progressed After Chemotherapy

  Life Sciences Jobs   ...

Quick Search
Advertisement
 

review and buy Bariatric Surgery market research data and corporate reports here